Fascin expression in progression and prognosis of hepatocellular carcinoma
Tomohiro Iguchi(Fukuoka Higashi Medical Center), Masazumi Tsuneyoshi(Sanno Medical Center), Kensaku Sanefuji(Kyushu University), K Sugimachi(National Hospital Organization Kyushu Cancer Center), Kenji Umeda(Kyushu University), Tomonobu Gion(Kyushu University), Akinobu Taketomi(Hokkaido University), Nobuhiro Fujita(Kyushu University), Shinichi Aishima(Saga University), Yoshihiko Maehara(Kyushu University)
Cited by 47
Related Papers
Expression profile of class I histone deacetylases in human cancer tissues
|Oncology Reports|2007|341
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244